Literature DB >> 17566290

Eppin: an epididymal protease inhibitor and a target for male contraception.

M G O'Rand1, E E Widgren, Zengjun Wang, R T Richardson.   

Abstract

Eppin (epididymal protease inhibitor) is one of several serine protease (or serine protease-like) inhibitors that are encoded by genes on human chromosome 20 and on mouse chromosome 2. Here we review our current knowledge of human and mouse Eppin genes and the Eppin protein in the context of protease inhibitors. Antibodies to Eppin in immunized male monkeys provide an effective and reversible contraceptive and these antibodies may be effective by interfering with Eppin's interaction with semenogelin during ejaculation. We review Eppin-semenogelin interaction and present a working model in the context of the hydrolysis of semenogelin by prostate specific antigen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566290

Source DB:  PubMed          Journal:  Soc Reprod Fertil Suppl        ISSN: 1747-3403


  8 in total

Review 1.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

Review 2.  New frontiers in nonhormonal male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Contraception       Date:  2010-05-06       Impact factor: 3.375

3.  Identification of increased amounts of eppin protein complex components in sperm cells of diabetic and obese individuals by difference gel electrophoresis.

Authors:  Uwe Paasch; Falk Heidenreich; Theresia Pursche; Eberhard Kuhlisch; Karina Kettner; Sonja Grunewald; Jürgen Kratzsch; Gunnar Dittmar; Hans-Jürgen Glander; Bernard Hoflack; Thomas M Kriegel
Journal:  Mol Cell Proteomics       Date:  2011-04-27       Impact factor: 5.911

Review 4.  Non-hormonal male contraception: A review and development of an Eppin based contraceptive.

Authors:  Michael G O'Rand; Erick J R Silva; Katherine G Hamil
Journal:  Pharmacol Ther       Date:  2015-11-22       Impact factor: 12.310

Review 5.  Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells.

Authors:  Oleg Shuvalov; Alyona Kizenko; Alexey Petukhov; Olga Fedorova; Alexandra Daks; Nikolai Barlev
Journal:  Cell Death Discov       Date:  2021-05-08

6.  Preparation, characterization, and determination of immunological activities of transfer factor specific to human sperm antigen.

Authors:  Jianwei Zhou; Cui Kong; Zhaohong Yuan; Junmin Luo; Rui Ma; Jiang Yu; Jinghe Cao
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

7.  Investigation in vitro Expression of CatSper Sub Fragment followed by Production of Polyclonal Antibody: Potential Candidate for The Next Generation of Non Hormonal Contraceptive.

Authors:  Mahboobeh Nazari; Manouchehr Mirshahi; Seyed-Javad Mowla; Taravat Bamdad; Sina Sarikhani
Journal:  Cell J       Date:  2012-12-12       Impact factor: 2.479

Review 8.  Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†.

Authors:  Deborah J Anderson; Joseph A Politch; Richard A Cone; Larry Zeitlin; Samuel K Lai; Philip J Santangelo; Thomas R Moench; Kevin J Whaley
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.